Reading GNSS? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track GNSS free→Reading GNSS? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track GNSS free→QuarterlyIQ Insights · GNSS
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Entry into a Material Definitive Agreement. On June 9, 2026, Genasys Inc., a Delaware corporation (the “Company”), entered into a Loan Agreement (the “Loan Agreement”) with Maran Partners Fund, LP, a Delaware limited partnership (the “Lender”), pursuant to which the Lender extended an unsecured term loan to the Company in the principal amount of $4.3 million (the “Loan”). The closing under the Loan Agreement also occurred on June 9, 2026. The proceeds of the Loan, net of the origination fee (…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The disclosure set forth under
Entry into a Material Definitive Agreement. On May 12, 2026, Genasys Inc. (the “Company”) entered into a Second Amendment to Term Loan and Security Agreement (the “Amendment”) among the Company, Evertel Technologies, LLC, Zonehaven LLC, Genasys Puerto Rico, LLC, the lenders from time to time party thereto and Cantor Fitzgerald Securities, as administrative agent and collateral agent, which extended the maturity date for the term loan provided to the Company under that certain Term Loan and Se…
Results of Operations and Financial Condition. The following information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition,” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information, including Exhibit 99.1, shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless o…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The disclosure set forth under
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 26, 2026, the Board of Directors (the “Board”) of Genasys Inc., a Delaware corporation (the “Company”), elected Lawrence F. Hagenbuch as a director, to hold office until the Company’s next annual meeting of stockholders and until his successor has been duly elected and qualified, and appointed Mr. Hagenbuch to serve as the chairman of the…
Results of Operations and Financial Condition. The following information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition,” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information, including Exhibit 99.1, shall not be incorporated by reference into any filing of Genasys Inc. (the “Company”), whether made before or after the date her…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 26, 2026, the Board of Directors (the “Board”) of Genasys Inc. (the “Company”) and the Compensation Committee of the Board (the “Compensation Committee) approved the following compensation for Richard Danforth, the Company’s Chief Executive Officer, for the Company’s 2026 fiscal year: a base salary of $490,000, a cash bonus plan based on…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 24, 2025, the Board of Directors (the “Board”) of Genasys Inc. (the “Company”) promoted Ms. Cassandra Hernandez-Monteon to the position of Chief Financial Officer, Treasurer and Secretary, a role she had held on an interim basis since July 1, 2025. The Board also increased Ms. Hernandez-Monteon’s base salary to $275,000 and approved a b…
Regulation FD Disclosure. In accordance with the terms of the First Amendment, dated May 9, 2025, to Term Loan and Security Agreement among the Company, Evertel Technologies, LLC, Zonehaven LLC, Genasys Puerto Rico, LLC, the lenders from time to time party thereto and Cantor Fitzgerald Securities, as administrative agent and collateral agent, on December 29, 2025, the Company repaid in full the additional $4 million term loan extended pursuant to such amendment, plus related interest and fees…
Entry into a Material Definitive Agreement. On December 19, 2025, Genasys Inc., a Delaware corporation (the “Company”), entered into an Amended and Restated Cooperation Agreement (the “A&R Cooperation Agreement”) with Nicoya Capital LLC, Nicoya Fund LLC and Nicoya Genasys-SPV LLC (collectively, the “Investor Parties”), affiliates of Company director R. Rimmy Malhotra, which amended and restated the terms of the Cooperation Agreement, dated as of January 14, 2025, by and between the Company an…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. In accordance with the A&R Cooperation Agreement, the Board nominated Messrs. Danforth, Dodd, Fugate and Malhotra and Ms. Schmeiser for election to the Board at the 2026 Annual Meeting. As a result, Mark Culhane will not stand for re-election, which is not because of a disagreement with the Company on any matter relating to the Company's operations…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 4, 2025, Richard H. Osgood III, notified the Board of Directors (the “Board”) of Genasys Inc. (the “Company”) that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Mr. Osgood will continue to serve as a director for the remainder of his term until the Annual Meeting. His deci…
Results of Operations and Financial Condition. The following information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition,” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information, including Exhibit 99.1, shall not be incorporated by reference into any filing of Genasys Inc. (the “Company”), whether made before or after the date her…
Results of Operations and Financial Condition. The following information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition,” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information, including Exhibit 99.1, shall not be incorporated by reference into any filing of Genasys Inc. (the “Company”), whether made before or after the date her…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously reported by Genasys Inc. (the “Company”) on Form 8-K filed on May 13, 2025, Dennis D. Klahn, Chief Financial Officer, Treasurer and Secretary of the Company, had informed the Company that he intended to retire from all positions he holds with the Company and its subsidiaries during the fourth fiscal quarter of 2025. The effective date…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 13, 2025, Dennis D. Klahn, Chief Financial Officer of the Company, informed the Company that he intends to retire from all positions he holds with the Company and its subsidiaries during the fiscal fourth quarter of 2025. Mr. Klahn will remain in his role until his successor is chosen and will help ensure a smooth and orderly transition. The…
Results of Operations and Financial Condition. The following information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition,” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information, including Exhibit 99.1, shall not be incorporated by reference into any filing of Genasys Inc. (the “Company”), whether made before or after the date her…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 2025 Equity Incentive Plan On January 27, 2025, the Board of Directors of Genasys Inc. (the “Company”) approved the Genasys Inc. 2025 Equity Incentive Plan (the “2025 Plan”), which was approved by the Company’s stockholders at the 2025 Annual Meeting of the Stockholders held March 17, 2025. Eligibility and Administration. Employees (including offic…
Results of Operations and Financial Condition. The following information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition,” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Such information, including Exhibit 99.1, shall not be incorporated by reference into any filing of Genasys Inc. (the “Company”), whether made before or after the date her…
Entry into a Material Definitive Agreement. On January 14, 2025, Genasys Inc., a Delaware corporation (the “Company”), entered into a Cooperation Agreement (the “Cooperation Agreement”) with Nicoya Capital LLC, Nicoya Fund LLC and Nicoya Genasys-SPV LLC (the “Investor Parties”). Pursuant to the Cooperation Agreement, the Company agreed to, among other things, increase the number of members of the Board of Directors of the Company (the “Board”) from six to seven members and appoint R. Rimmy Ma…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. In accordance with the Cooperation Agreement, on January 14, 2025, the Board increased the number of members of the Board to seven and appointed Mr. Malhotra as a member of the Board, effective January 15, 2025, with an initial term expiring at the 2025 annual meeting of stockholders of the Company. Mr. Malhotra was also appointed to the Audit Comm…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.